Literature DB >> 31338167

Impact of drugs on hypoglycaemia in hospitalised patients.

Frederik Vandenberghe1, Corinne Challet1, Mathias Maitrejean2, Laurent Christin3, Nicolas Schaad1,4,5.   

Abstract

OBJECTIVES: Hospital admission rates for hypoglycaemia now exceed those for hyperglycaemias among older adults. A growing number of reports associating hypoglycaemia with non-antidiabetic drugs have been published. Clinical pharmacists are often faced with hypoglycaemia in patients taking multiple medications. This study assessed the potential relationship between prescribed drugs and episodes of hypoglycaemia during hospitalisation.
METHODS: Point-of-care blood glucose values and prescribed drugs were analysed in patients admitted to a regional hospital. Hypoglycaemia cases were defined as patients with at least one hypoglycaemic event (random glucose value ≤3.9 mmol/L), and normoglycaemic cases as those with random glucose concentrations within the range of 4.5-5.8 mmol/L. Analyses were carried out using multivariate logistic regressions and Cox proportional hazard models.
RESULTS: 373 patients (53% males; median age=74 years) were included in the analysis and of these, 64 (17%) had at least one hypoglycaemic event. Patients who experienced a hypoglycaemic event had a longer length of stay (median=10 vs 7 days, p<0.01) and a higher rate of antidiabetic drugs prescription (83% vs 37%, p<0.01). The number of non-antidiabetic drugs was associated with an increased risk of hypoglycaemia during hospitalisation (HR 2.3, 95% CI 1.4 to 4, p<0.01). After adjusting by confounders, heparin and pantoprazole were found to be associated with hypoglycaemia.
CONCLUSIONS: The relationship between hypoglycaemia and polypharmacy reinforces the advice to limit polymedication as much as possible, especially in elderly patients. This result underlines the potential involvement of clinical pharmacists with the aim to reduce the risk of hypoglycaemia during hospitalisation.

Entities:  

Keywords:  clinical pharmacology; diabetes & endocrinology; geriatric medicine; internal medicine; side effects of drugs

Year:  2018        PMID: 31338167      PMCID: PMC6613918          DOI: 10.1136/ejhpharm-2017-001375

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  47 in total

1.  Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals.

Authors:  Deborah J Wexler; James B Meigs; Enrico Cagliero; David M Nathan; Richard W Grant
Journal:  Diabetes Care       Date:  2007-02       Impact factor: 19.112

2.  Glucose homeostasis abnormalities associated with use of gatifloxacin.

Authors:  Richard Frothingham
Journal:  Clin Infect Dis       Date:  2005-09-28       Impact factor: 9.079

Review 3.  Betablocker treatment in diabetes mellitus.

Authors:  P T Sawicki; A Siebenhofer
Journal:  J Intern Med       Date:  2001-07       Impact factor: 8.989

4.  The pharmacovigilance of pantoprazole: the results of postmarketing surveillance on 11 541 patients in England.

Authors:  Lynda V Wilton; Cheryl Key; Saad A W Shakir
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness.

Authors:  J N Henderson; K V Allen; I J Deary; B M Frier
Journal:  Diabet Med       Date:  2003-12       Impact factor: 4.359

6.  Hormonal counterregulation during severe hypoglycaemia under everyday conditions in patients with type 1 and insulin-treated type 2 diabetes mellitus.

Authors:  A Holstein; C Hammer; A Plaschke; M Ptak; J Kuhn; J Diekmann; K Kleesiek; E-H Egberts
Journal:  Exp Clin Endocrinol Diabetes       Date:  2004-09       Impact factor: 2.949

7.  Outpatient gatifloxacin therapy and dysglycemia in older adults.

Authors:  Laura Y Park-Wyllie; David N Juurlink; Alexander Kopp; Baiju R Shah; Therese A Stukel; Carmine Stumpo; Linda Dresser; Donald E Low; Muhammad M Mamdani
Journal:  N Engl J Med       Date:  2006-03-01       Impact factor: 91.245

8.  Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).

Authors:  Guillermo E Umpierrez; Dawn Smiley; Ariel Zisman; Luz M Prieto; Andres Palacio; Miguel Ceron; Alvaro Puig; Roberto Mejia
Journal:  Diabetes Care       Date:  2007-05-18       Impact factor: 19.112

9.  Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration.

Authors: 
Journal:  Diabetologia       Date:  2007-04-06       Impact factor: 10.122

10.  Clinical characterisation of severe hypoglycaemia--a prospective population-based study.

Authors:  A Holstein; A Plaschke; E-H Egberts
Journal:  Exp Clin Endocrinol Diabetes       Date:  2003-09       Impact factor: 2.949

View more
  1 in total

1.  Influence of Pharmacist Intervention on Re-Elevation of Glycated Hemoglobin for Diabetic Outpatients.

Authors:  Takayoshi Maiguma; Atsushi Komoto; Emi Shiraga; Sae Hagiwara; Junko Onishi; Miyoshi Li; Daisuke Teshima
Journal:  Hosp Pharm       Date:  2019-10-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.